Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Epithelial Yap/Taz are required for functional alveolar regeneration following acute lung injury
Gianluca T. DiGiovanni, … , Jonathan A. Kropski, Jason J. Gokey
Gianluca T. DiGiovanni, … , Jonathan A. Kropski, Jason J. Gokey
Published September 7, 2023
Citation Information: JCI Insight. 2023;8(19):e173374. https://doi.org/10.1172/jci.insight.173374.
View: Text | PDF
Research Article Pulmonology

Epithelial Yap/Taz are required for functional alveolar regeneration following acute lung injury

  • Text
  • PDF
Abstract

A hallmark of idiopathic pulmonary fibrosis (IPF) and other interstitial lung diseases is dysregulated repair of the alveolar epithelium. The Hippo pathway effector transcription factors YAP and TAZ are implicated as essential for type 1 and type 2 alveolar epithelial cell (AT1 and AT2) differentiation in the developing lung, yet aberrant activation of YAP/TAZ is a prominent feature of the dysregulated alveolar epithelium in IPF. In these studies, we sought to define the functional role of YAP/TAZ activity during alveolar regeneration. We demonstrated that Yap and Taz were normally activated in AT2 cells shortly after injury, and deletion of Yap/Taz in AT2 cells led to pathologic alveolar remodeling, failure of AT2-to-AT1 cell differentiation, increased collagen deposition, exaggerated neutrophilic inflammation, and increased mortality following injury induced by a single dose of bleomycin. Loss of Yap/Taz activity prior to an LPS injury prevented AT1 cell regeneration, led to intraalveolar collagen deposition, and resulted in persistent innate inflammation. These findings establish that AT2 cell Yap/Taz activity is essential for functional alveolar epithelial repair and prevention of fibrotic remodeling.

Authors

Gianluca T. DiGiovanni, Wei Han, Taylor P. Sherrill, Chase J. Taylor, David S. Nichols, Natalie M. Geis, Ujjal K. Singha, Carla L. Calvi, A. Scott McCall, Molly M. Dixon, Yang Liu, Ji-Hoon Jang, Sergey S. Gutor, Vasiliy V. Polosukhin, Timothy S. Blackwell, Jonathan A. Kropski, Jason J. Gokey

×

Figure 2

Deletion of YAP/TAZ leads to failed alveolar repair following single-dose bleomycin induced lung injury.

Options: View larger image (or click on image) Download as PowerPoint
Deletion of YAP/TAZ leads to failed alveolar repair following single-dos...
(A) Schematic of injury model in which mice were treated with tamoxifen the same day as bleomycin-induced lung injury. (B) Survival curve of WT and YTdel bleomycin- or saline-treated mice out to 28 days after injury. Statistics determined using Mantel-Cox test. (C) Masson’s trichrome staining of tissue sections from WT and YTdel mice at day 28 after bleomycin or PBS. (D) Soluble, insoluble, and total collagen quantification from WT and YTdel at day 28 after saline or bleomycin. (E) Quantification of total injured lung area in respective groups at day 28 after saline/bleomycin. n = 7 WT saline, n = 9 YTdel saline, n = 9 WT bleomycin, and n = 12 YTdel bleomycin mice. (F and G) Quantification of total Hopx+ cells or Sp-C+ cells per 20× field of view in each group. n = 10 WT saline-, n = 9 YTdel saline-, n = 12 WT bleomycin-, and n = 18 YTdel bleomycin-treated mice. (H and I) Quantification of Sp-Ctomato lineage–labeled Hopx+ or Sp-C+ AT2 cells 28 days after bleomycin. (J) Immunofluorescence analysis of Sp-Ctomato lineage labeled cells (red) and Hopx+ (green) AT1 cells at 28 days after injury. (K) Immunofluorescence analysis of Sp-Ctomato lineage–labeled cells (red) and Sp-C+ (white) AT2 cells at 28 days after injury. n = 5 WT saline, n = 5 YTdel saline, n = 10 WT bleomycin, and n = 15 YTdel bleomycin mice. Scale bars: 200 µm (C), 50 µm (J and K). Statistical analysis in D–I was performed using 1-way ANOVA and Tukey’s post hoc comparison.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts